FC25 Interdisciplinary clinical boards on chronic inflammatory diseases: beneficial effects on psoriasis

Abstract Many chronic inflammatory diseases may involve various organs of the human body and need interdisciplinary care for the benefit of affected patients. Therefore, interdisciplinary clinical boards on chronic inflammatory diseases (ICB) are increasingly established, yet their prerequisites with regard to the composition of participants, diseases to be covered, frequency of meetings and administration as well as documentation still need to be clarified. In 2016 an ICB was inaugurated at the University Hospital of Erlangen as part of Deutsches Zentrum Immuntherapie (DZI). During once-weekly meetings with compulsory and minimal participation of a dermatologist, rheumatologist and gastroenterologist between 5 and 15 patients are discussed and diagnostic as well as therapeutic issues decided. The meeting parameters between 2020 and 2024 have been analysed to evaluate the quality and outcome of ICB activities. Within this interval, 1067 consultations took place covering 804 patients, 13% below the age of 18 years. The main topics were induction of systemic treatment in 15% of cases and change of therapy in 34%. Diagnostic issues were raised in 10% of cases. Twenty-four percentage of requests were dermatologic, 11% gastroenterologic and 8% rheumatologic. Psoriasis accounted for 22% of cases, psoriasis arthritis 2%, and inflammatory bowel disease 9%. Sixty-two percentage of ICB-recommendations were followed, and 24% were not followed. Recommendations by ICB resulted in a clinical improvement of disease in 38% of cases, and diagnostic procedures were followed in 27% of cases. This study documents a positive structural and process quality, whereas the quality of results with regard to the improvement of disease activity still needs to be ameliorated.